Page last updated: 2024-11-06

floxuridine and Conjugate Nystagmus

floxuridine has been researched along with Conjugate Nystagmus in 1 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, DW1
Kim, HJ1
Kim, DE1
Roh, JK1

Other Studies

1 other study available for floxuridine and Conjugate Nystagmus

ArticleYear
Doxifluridine-induced neurotoxicity with normal dihydropyrimidine dehydrogenase activity.
    Neurology, 2004, Jun-08, Volume: 62, Issue:11

    Topics: Aged; Antimetabolites, Antineoplastic; Biotransformation; Cerebellar Nuclei; Chemotherapy, Adjuvant;

2004